Abstract
Oestrogen receptor (ER) is arguably the single most important biological predictive factor that exists today. In the last 10 years or so, however, our understanding of ER biology has undergone a paradigm shift following the identification of a second ER, ERbeta, with the original ER being renamed ERalpha. A number of isoforms have additionally been described, especially for ERbeta. Our knowledge of ER signalling has also increased with the recognition of accessory co-regulatory proteins, which help direct the transcriptional cascade. Here we outline these changes and discuss what biological and clinical implications these could have in the mammary gland.
Original language | English |
---|---|
Pages (from-to) | 499-506 |
Number of pages | 8 |
Journal | The Journal of pathology |
Volume | 211 |
Issue number | 5 |
Early online date | 18 Jan 2007 |
DOIs | |
Publication status | Published - Apr 2007 |
Keywords
- Animals
- Breast
- Breast Neoplasms
- Drug Resistance, Neoplasm
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Female
- Humans
- Mice
- Mice, Knockout
- Phosphorylation
- Receptor, Epidermal Growth Factor
- Receptors, Estrogen
- Receptors, Progesterone
- Signal Transduction
- Transcription, Genetic
- Journal Article
- Research Support, Non-U.S. Gov't
- Review